There’s been a lot of fuss regarding the novel covid 19 vaccines and myocarditis. Now, it seems that more evidence is revealed by a brand new study and you can check out more details below.
The study’s abstract begins by noting the following:
“autopsy findings of a 22-year-old man who developed chest pain 5 days after the first dose of the BNT162b2 mRNA vaccine and died 7 hours later. Histological examination of the heart revealed isolated atrial myocarditis, with neutrophil and histiocyte predominance. Immunohistochemical C4d staining revealed scattered single-cell necrosis of myocytes which was not accompanied by inflammatory infiltrates.”
The same notes reveal more info:
“Extensive contraction band necrosis was observed in the atria and ventricles. There was no evidence of microthrombosis or infection in the heart and other organs. The primary cause of death was determined to be myocarditis, causally-associated with the BNT162b2 vaccine.”
The study analyzes the case of a 22-year-old male military recruit who died following the covid vaccine. The autopsy was performed 24 hours following his death and we strongly suggest that you take a look at the original study that reveals the death cause.
Covid new studies
The other day, we were revealing that the drug is effective against the covid 19 variant Omicron, according to a new report.
“The company’s EVUSHELD retains neutralization activity against omicron, according to ‘live’ virus neutralization data from both University College Oxford and Washington University School of Medicine,” ABC News reported.
The online publication Daily Wire revealed that AstraZeneca’s treatment was authorized on December 8 but used to prevent covid 19 “among people who are immune-compromised, or people who are allergic to vaccine components. It is not authorized as a way to treat COVID-19 among people who have already tested positive,” ABC reported.
We suggest that you check out the previous article that we posted the other day.